Pancreatic Cancer Research

ResearcherCentral South UniversityActive in the last 2 years

Shuai Liang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8562-088X; OpenAlex author ID A5103165302. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 3

  1. Extrapancreatic extension modifies chemotherapy benefit in resected pancreatic ductal adenocarcinoma: a population-based cohort study. Co-author DOI 10.1038/s41598-026-47990-w↗
  2. Antitumor potentials of onco-microbial in Chinese patients with pancreatic cancer. Co-author DOI 10.1016/j.heliyon.2024.e40890↗
  3. Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis. Co-author DOI 10.1080/15476286.2019.1649585↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xuejun Gong · 1 shared paper, 2026 · strength 0.39
  2. Wei Wei · 1 shared paper, 2026 · strength 0.39
  3. Yebin Lu · 2 shared papers, 2019–2024 · strength 0.33
  4. Yongchao Gao · 1 shared paper, 2024 · strength 0.22
  5. Wei Zhang · 1 shared paper, 2024 · strength 0.22
  6. Zhenglin Ou · 1 shared paper, 2019 · strength 0.11
  7. Zhen Luo · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.